Nonmelanoma Skin Cancer
From the Journals
Does Medicare Advantage Offer Higher-Value Chemotherapy?
Researchers conducted a cohort study to look at Medicare Advantage enrollment and treatment patterns for patients with cancer receiving...
Feature
AACR Cancer Progress Report: Big Strides and Big Gaps
The report focused on strides made in cancer care, prevention, and early detection and highlighted areas where more research and attention are...
Case Letter
Inspection of Deep Tumor Margins for Accurate Cutaneous Squamous Cell Carcinoma Staging
To the Editor:
Histopathologic analysis of debulk specimens in Mohs micrographic surgery (MMS) may augment identification of high-risk...
Case Letter
Transient Eruption of Verrucous Keratoses During Encorafenib Therapy: Adverse Event or Paraneoplastic Phenomenon?
To the Editor:
Mutations of the BRAF protein kinase gene are implicated in a variety of malignancies.1 BRAF...
From the Journals
Cancer Risk: Are Pesticides the New Smoking?
A recent study evaluated cancer risks in the US population using a model that accounts for pesticide use and adjusts for various factors.
Feature
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
Researchers analyzed whole genome sequencing data from 10,866 women in the WHI to explore possible associations between CHIP, mCA, and solid...
Latest News
Study Indicates Skin Cancer Risk Elevated Among Veterans
“Public health measures seeking to address veteran healthcare differences could emphasize primary preventive strategies to mitigate risk,” the...
From the Journals
Cancer Cases, Deaths in Men Predicted to Surge by 2050
Researchers analyzed data from the 2022 Global Cancer Observatory (GLOBOCAN), which provides national-level estimates for cancer cases and deaths...
Latest News
Support for Laser Treatment to Reduce NMSC Risk is Increasing
There is a “growing body of research that demonstrates we are improving the health of our patients’ skin with certain types of laser treatments,...
Commentary
Cancer Treatment 101: A Primer for Non-Oncologists
Doctor explains why he thinks time of diagnosis is the best time for molecular testing of a new malignant tumor.
Feature
When Childhood Cancer Survivors Face Sexual Challenges
The disruptions caused by cancer and its treatment can interfere with normal physiological and psychological development, leading to issues with...